Blue Jays' Rotation Reckoning: Scherzer's Return Faces a Rival Nobody Expected

Max Scherzer threw 22 pitches in a bullpen session Monday in Toronto and, if he wakes Wednesday without pain after another appearance at Yankee Stadium, the Blue Jays will greenlight a return to regular-season action. The timing is tight—Toronto's rotation has fractured. José Berríos is having elbow surgery Wednesday. Shane Bieber is still ramping from injury. That No. 5 spot turns Thursday in the Bronx, and the team will lean on whoever's available. The question that matters for baseball purposes is whether Scherzer can be the pitcher Toronto needs him to be, not the one they hope he'll become.

Scherzer's 2025 regular season was a 5.19 ERA disaster across 17 starts before the forearm tendinitis and ankle injury sidelined him in late April. This season's five-start sample sits at 9.64 ERA with a 10:8 strikeout-to-walk ratio over 18⅔ innings—though Scherzer and the organization blame mechanical disruption caused by the ankle. That's a reasonable explanation. It's also untestable until he actually pitches. The Blue Jays organization still believes in his Hall of Fame pedigree, which is fine; organizational belief doesn't move fastballs. His 2024 postseason work was strong, but October performance doesn't pay regular-season dividends when October ball uses different arms in different roles. Toronto needs effective innings right now, not nostalgia.

Spencer Miles, meanwhile, has become the rotation's stabilizing element precisely because expectations for him are granular and honest. A Rule 5 pick who'd undergone arm and back surgery before breaking camp, Miles has never pitched above Single-A professionally. Yet in his new bulk-innings role, he's thrown three scoreless innings on May 10, then 3⅔ scoreless Saturday with his pitch count climbing to 56. Manager John Schneider envisions a ceiling of 80 pitches per outing—a conservative ramp that respects Miles' injury history and limited professional mileage. The Blue Jays have publicly committed to consistency in his role rather than the whiplash of shuttling him between opener duty and relief. That structural commitment is both a gift and a cage: it locks Miles into a defined usage pattern, which shields him from volatility but also means he's fully invested in one track.

For prop bettors, the rotation competition creates a direct leverage play on Scherzer's strikeout and innings-pitched lines. If Scherzer returns and pitches, he'll likely be heavily backed by casual action seeking redemption narratives and Hall of Famer nostalgia—the kind of chasing that inflates strikeout props for recovering veterans. However, his 2024 regular-season walk rate was elevated, and a pitcher altering mechanics due to ankle injury typically loses command before he finds it again. The Blue Jays' caution (multiple rehab starts before full activation) also suggests Scherzer's first few regular-season outings will be innings-limited, probably in the 4-5 range, which makes overs on his total strikeouts vulnerable to missing the volume entirely. More durable: fade Scherzer's strikeout props in his first two or three starts back. The market will price him as a near-full pitcher; the team will use him as a partial one. That gap survives multiple innings.

Miles' role is more stable but lower-ceiling. His strikeout prop will depend entirely on pitch-count management—80-pitch appearances don't generate the volume for big K numbers—but his consistency makes him a reliable under bet if the line is set expecting starter-length workloads. The real edge is on Blue Jays team totals: with Berríos down, Bieber ramping, and Scherzer's return timeline murky, Toronto will cycle through games with reduced rotation depth. Games where Miles takes the bulk role and Scherzer isn't yet full-strength become opportunities to target team unders. The Blue Jays' lineup is real, but their starting pitching leverage has evaporated.